# A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279

> **NCT02169973** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-42165279
- **DRUG:** 11C-MK-3168

## Key facts

- **NCT ID:** NCT02169973
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02169973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02169973, "A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02169973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*